Cargando…

Cardioprotection by kappa-opioid receptor agonist U50488H is mediated by opioidergic regulation but not by calcium current modulation

BACKGROUND: Because the κ-opioid receptor (OR) agonist U50488H stimulates opioidergic regulation and inhibits L-type Ca(2+) channels, this study was aimed at assessing the roles of OR and L-type Ca(2+) channels on U50488H-induced cardioprotection. METHODS: Langendorff-perfused rat hearts were subjec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chun, Kook Jin, Jang, Young Ho, Kim, June Hong, Kim, Jun, Park, Yong Hyun
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Society of Anesthesiologists 2010
Materias:	Experimental Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2872865/ https://www.ncbi.nlm.nih.gov/pubmed/20498795 http://dx.doi.org/10.4097/kjae.2010.58.2.162

Ejemplares similares

The Differential Effects of a Selective Kappa-Opioid Receptor Agonist, U50488, in Guinea Pig Heart Tissues
por: Hung, Chi-Feng, et al.
Publicado: (2015)

Optimisation of the Anti-Trypanosoma brucei Activity of the Opioid Agonist U50488
por: Smith, Victoria C, et al.
Publicado: (2011)

Evaluation of Antinociceptive Effects of Chitosan-Coated Liposomes Entrapping the Selective Kappa Opioid Receptor Agonist U50,488 in Mice
por: Mititelu Tartau, Liliana, et al.
Publicado: (2021)

The kappa opioid receptor agonist U50,488H did not affect brain-stimulation reward while it elicited conditioned place aversion in mice
por: Huang, Peng, et al.
Publicado: (2020)

The κ-Opioid Receptor Agonist U50488H Ameliorates Neuropathic Pain Through the Ca(2+)/CaMKII/CREB Pathway in Rats
por: Zhang, Xiao-Min, et al.
Publicado: (2022)

Activation of κ-opioid receptor by U50,488H improves vascular dysfunction in streptozotocin-induced diabetic rats
por: Zhou, Xuan, et al.
Publicado: (2015)

Behavioral meaningful opioidergic stimulation activates kappa receptor gene expression
por: Teodorov, E., et al.
Publicado: (2012)

κ-opioid receptor agonist U50488H attenuates postoperative cognitive dysfunction of cardiopulmonary bypass rats through the PI3K/AKT/Nrf2/HO-1 pathway
por: Fan, Jianing, et al.
Publicado: (2021)

Therapeutic Potential of Kappa Opioid Agonists
por: Beck, Tyler C., et al.
Publicado: (2019)

Addressing Hazards from Unscheduled Novel Psychoactive Substances as Research Chemicals: The Case of U-50488
por: Amin, Zubair M, et al.
Publicado: (2017)

κ-opioid receptor agonist, U50488H, inhibits pyroptosis through NLRP3 via the Ca(2+)/CaMKII/CREB signaling pathway and improves synaptic plasticity in APP/PS1 mice
por: Song, Xiaofu, et al.
Publicado: (2021)

Kappa-opioid receptor activation during reperfusion limits myocardial infarction via ERK1/2 activation in isolated rat hearts
por: Kim, June Hong, et al.
Publicado: (2011)

Orvinols with Mixed Kappa/Mu Opioid Receptor Agonist Activity
por: Greedy, Benjamin M., et al.
Publicado: (2013)

Renal responses produced by microinjection of the kappa opioid receptor agonist, U50-488H, into sites within the rat lamina terminalis
por: Franklin, Cynthia, et al.
Publicado: (2015)

Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists
por: Maslov, Leonid N, et al.
Publicado: (2016)

Characterization of Pyrrolidinyl-hexahydro-pyranopiperazines as a Novel Kappa Opioid Receptor Agonist Scaffold
por: Reed, Brian, et al.
Publicado: (2022)

Effects of mu- and kappa-2 opioid receptor agonists on pain and rearing behaviors
por: Neubert, John K, et al.
Publicado: (2007)

Novel Kappa-Opioid Receptor Agonist for the Treatment of Cholestatic Pruritus: Systematic Review
por: Bailey, Adrian Joseph Michel, et al.
Publicado: (2022)

nor-BNI Antagonism of Kappa Opioid Agonist-Induced Reinstatement of Ethanol-Seeking Behavior
por: Harshberger, Erin, et al.
Publicado: (2016)

Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation
por: Shokirova, Hurramhon, et al.
Publicado: (2021)

Opioidergic pathways and kisspeptin in the regulation of female reproduction in mammals
por: Uenoyama, Yoshihisa, et al.
Publicado: (2022)

Diuretic Activity of a Novel Peripherally-Restricted Orally-Active Kappa Opioid Receptor Agonist
por: Beck, Tyler C., et al.
Publicado: (2019)

Antipruritic Effect of Nalbuphine, a Kappa Opioid Receptor Agonist, in Mice: A Pan Antipruritic
por: Inan, Saadet, et al.
Publicado: (2021)

Are Calcium Antagonists Cardioprotective?
por: Kendall, M. J., et al.
Publicado: (1985)

Pharmacological profiles of opioid ligands at Kappa opioid receptors
por: Gharagozlou, Parham, et al.
Publicado: (2006)

Development of a Peptide-Derived Orally-Active Kappa-Opioid Receptor Agonist Targeting Peripheral Pain
por: Hughes, Jr, Francis M., et al.
Publicado: (2013)

Evaluation of the abuse potential of difelikefalin, a selective kappa‐opioid receptor agonist, in recreational polydrug users
por: Shram, Megan J., et al.
Publicado: (2021)

Sex Differences in Kappa Opioid Receptor Agonist Mediated Attenuation of Chemotherapy-Induced Neuropathic Pain in Mice
por: Paton, Kelly F., et al.
Publicado: (2022)

Polyphenol (-)-epigallocatechin gallate-induced cardioprotection may attenuate ischemia-reperfusion injury through adenosine receptor activation: a preliminary study
por: Lee, Sang Kwon, et al.
Publicado: (2012)

Cardioprotective Effect of the SDF-1α/CXCR4 Axis in Ischemic Postconditioning in Isolated Rat Hearts
por: Kim, Jeong Su, et al.
Publicado: (2017)

Modulation of G-protein activation, calcium currents and opioid receptor phosphorylation by the pH-dependent antinociceptive agonist NFEPP
por: Celik, Melih Özgür, et al.
Publicado: (2023)

Propofol-induced inhibition of intestinal peristalsis involves enteric opioidergic pathways
por: Herbert, MK, et al.
Publicado: (2000)

The antinociceptive effect of artemisinin on the inflammatory pain and role of GABAergic and opioidergic systems
por: Dehkordi, Faraz Mahdian, et al.
Publicado: (2019)

Hedonic processing in humans is mediated by an opioidergic mechanism in a mesocorticolimbic system
por: Buchel, Christian, et al.
Publicado: (2018)

Dopaminergic and opioidergic regulation during anticipation and consumption of social and nonsocial rewards
por: Korb, Sebastian, et al.
Publicado: (2020)

Agonist-Promoted Phosphorylation and Internalization of the Kappa Opioid Receptor in Mouse Brains: Lack of Connection With Conditioned Place Aversion
por: Chen, Chongguang, et al.
Publicado: (2022)

Discovery of 7-Azanorbornane-Based Dual Agonists for the Delta and Kappa Opioid Receptors through an In Situ Screening Protocol
por: Karaki, Fumika, et al.
Publicado: (2023)

Role of kappa‐opioid and mu‐opioid receptors in pruritus: Peripheral and central itch circuits
por: Kim, Brian S., et al.
Publicado: (2022)

GABAergic synaptic response and its opioidergic modulation in periaqueductal gray neurons of rats with neuropathic pain
por: Hahm, Eu-Teum, et al.
Publicado: (2011)

Nanobody-enabled monitoring of kappa opioid receptor states
por: Che, Tao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4rd5d13hhorpgb0nk6j44c1bib